We did not observe a significant difference in the presence of anti-PTM antibodies in patients positive or negative for ANA or SMA, with the exception of anti-MAA positivity and ANA positivity in patients with AIH (Chi-2 (1) > = 4.687, p = 0.030). This evidence concerns the gene NAA10 and autoimmune hepatitis.